FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology. A group of inventions is described, including a screening method, a fused protein for binding to a target molecule (variants), a binding element for binding to a target molecule, a method for obtaining a library of binding elements, a library of binding elements and a method for obtaining a binding element. In one variant, the screening method includes the stages of providing the initial library of binding elements, screening the initial library to identify binding elements that exhibit binding activity and identifying one or more binding elements in the specified initial library that exhibit the specified binding activity.
EFFECT: invention expands the arsenal of screening tools.
118 cl, 43 dwg, 33 tbl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
LIBRARIES OF SYNTHETIC POLYPEPTIDES AND METHODS OF OBTAINING VERSIONS OF POLYPEPTIDES WITH NATURAL DIVERSITY | 2010 |
|
RU2562163C2 |
PARTNERS OF SPECIFIC BINDING WITH NGF | 2006 |
|
RU2406728C2 |
ANTIBODIES SPECIFIC TO CATALYTIC DOMAIN OF FOKI NUCLEASE, AND WAYS OF USE THEREOF | 2020 |
|
RU2830090C2 |
ANTIGENS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE | 2012 |
|
RU2612878C2 |
ANTAGONISTS AND METHOD OF USING SAID ANTAGONISTS | 2005 |
|
RU2401842C2 |
Fv LIBRARY BASED ON PROTEIN COMBINATIONS AND METHOD FOR ITS PRODUCTION | 2014 |
|
RU2639505C2 |
HUMAN IL-13 ANTIBODY MOLECULES | 2004 |
|
RU2387667C2 |
POLYPEPTIDE COMPRISING ANTIGEN-BINDING DOMAIN AND TRANSPORTING SEGMENT | 2018 |
|
RU2841528C2 |
ANTIGEN ASSOCIATED WITH RHEUMATOID ARTHRITIS | 2013 |
|
RU2649368C2 |
METHOD FOR GM-CSFRα INHIBITION IN PATIENT | 2012 |
|
RU2639546C2 |
Authors
Dates
2022-08-23—Published
2017-01-09—Filed